CoChat

Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy

Brugada, Ramon, Kelsey, Winifred, Lechin, Marcel, Zhao, Guiling, Yu, Qun-Tao, Zoghbi, William, Quinones, Miguel, Elstein, Eleanor, Omran, Ahmad, Rakowski, Harry, Wigle, Douglas, Liew, Choong-Chin, Sole, Michael, Roberts, Robert, Marian, Ali J. · 1997 · Journal of Investigative Medicine
Cited by 100

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: The phenotypic expression of left ventricular hypertrophy (LVH) in patients with hypertrophic cardiomyopathy (HCM) is variable. This phenotypic variability is not completely explained by the responsible mutations or other known factors. Recent data denote a role for the modifier genes and environmental factors. We studied the role of 3 potential modifier genes, ie, angiotensinogen (AGT), angiotensin II receptor 1, (AT1), and endothelin-1 (END1) on the phenotypic expression of LVH in patients with hypertrophic cardiomyopathy (HCM). Methods: The study population was comprised of 108 genetically independent patients with HCM. Left ventricular mass index (LVMI) and LVH score were determined per published protocols. The genotypes of AGT (M235T, T174M, and G-6A), AT1, and END1 were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or mutation-specific PCR (MS-PCR). Results: Male patients had higher mean LVMI and LVH score than female patients (146.0 ± 33.5 vs 129.4 ± 33.6, p = 0.01 and 6.0 vs 5.0, p = 0.010, respectively). Gender accounted for 4.8% and 5.4% of the variability of LVMI and LVH score, respectively. The END1 genotypes also had a significant influence on LVH scores accounting for 2.9% of their variability (p = 0.042). The median LVH score was greater in patients with the AA and AG genotypes, as compared to patients with the GG genotype (7.0 vs 5.0, p = 0.034). Neither the AGT nor the AT1 genotypes had a significant influence on the expression of LVH. In multivariate regression analysis, END1 and gender accounted for 7.3% of the variability of the LVH score (p = 0.007). Conclusions: Our results show that gender and the END1 gene modify the phenotypic expression of hypertrophy in patients with HCM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/108155899704500910

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 100

Metadata

Authors
Brugada, R., Kelsey, W., Lechin, M., Zhao, G., Yu, Q.-T., Zoghbi, W., Quinones, M., Elstein, E., Omran, A., Rakowski, H., Wigle, D., Liew, C.-C., Sole, M., Roberts, R., & Marian, A. J.
Venue
Journal of Investigative Medicine
Published
1997-12
Volume
45
Issue
9
Pages
542-551
ISSN
  • 1081-5589 (ISSN-L)
  • 1708-8267
OpenAlex
W153488610
Cited by
100
References
1
FWCI
2.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy. https://app.cochat.ai/papers/10.1177/108155899704500910
The paper
Brugada, R., Kelsey, W., Lechin, M., Zhao, G., Yu, Q.-T., Zoghbi, W., Quinones, M., Elstein, E., Omran, A., Rakowski, H., Wigle, D., Liew, C.-C., Sole, M., Roberts, R., & Marian, A. J. (1997). Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy. Journal of Investigative Medicine. https://doi.org/10.1177/108155899704500910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.